Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability
- 27 January 2015
- journal article
- Published by Springer Nature in neurogenetics
- Vol. 16 (3) , 161-168
Abstract
Genome-wide association studies (GWAS) underscore the genetic basis of multiple sclerosis (MS); however, only few of the newly reported genetic variations relevant in MS have been replicated or correlated for clinical/paraclinical phenotypes such as spinal cord atrophy in independent patient cohorts. We genotyped 141 MS patients for 58 variations reported to reach significance in GWAS. Expanded disability status scale (EDSS) and disease duration (DD) are available from regular clinical examinations. MRI included sagittal high-resolution 3D T1-weighted magnetization-prepared rapid acquisition gradient echo of the cervical cord region used for volumetry. Due dependency of mean upper cervical cord area (MUCCA) with EDSS and/or DD, correction operations were performed compensating for EDSS/DD. We assessed each MS risk locus for possible MUCCA association. We identified twelve risk loci that significantly correlated with MUCCA. For nine loci—BATF, CYP27B1, IL12B, NFKB1, IL7, PLEK, EVI5, TAGAP and nrs669607—patients revealed significantly higher degree of atrophy; TYK2, RGS1 and CLEC16A revealed inverse effects. The weighted genetic risk score over the twelve loci showed significant correlation with MUCCA. Our data reveal a risk gene depending paraclinical/clinical phenotype. Since MUCCA clearly correlates with disability, the candidates identified here may serve as prognostic markers for disability progression.Keywords
This publication has 19 references indexed in Scilit:
- Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2014
- The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cellsHuman Molecular Genetics, 2013
- Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects: Figure 1Journal of Medical Genetics, 2012
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- A multicenter assessment of cervical cord atrophy among MS clinical phenotypesNeurology, 2011
- HLA B*44Neurology, 2010
- Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scoreThe Lancet Neurology, 2009
- Multiple Sclerosis Severity ScoreNeurology, 2005
- Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesionsBrain, 2004
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001